Market Overview

Idenix Pharmaceuticals, Inc. Reports Q4 EPS of $(0.17), Inline; Revenue of $300.0K vs $740.0K Est

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Earnings News

 

Most Popular

Related Articles (IDIX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free